PURPOSE: The purpose of this study is to reveal the contribution of membrane components to the inhibitory effect of 2,6-di-O-methyl-beta-cyclodextrin (DM-beta-CyD) on P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (MRP2) function in vinblastine-resistant Caco-2 (Caco-2R) cell monolayers. METHODS: The transport of rhodamine-123 and 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) was studied in Caco-2R cell monolayers. P-gp and MRP2 residing in the monolayers and releasing in cell supernatants were detected by Western blotting. The mRNA levels of MDR1 and MRP2 were detected by reverse transcription-polymerase chain reaction (RT-PCR) method. Cholesterol, phospholipids, and proteins were mainly determined by each assay kit. RESULTS: Of various beta-cyclodextrin derivatives (beta-CyDs), DM-beta-CyD most significantly impaired the efflux function of P-gp and MRP2 without changing cell viability and membrane integrity. The treatment with CyDs did not change the mRNA levels of MDR1 and MRP2. DM-beta-CyD lowered cholesterol content and P-gp level in caveolar membranes. In addition, DM-beta-CyD released not only cholesterol and phospholipids but also proteins including P-gp and MRP2 from apical membranes of the monolayers. CONCLUSIONS: DM-beta-CyD may impair P-gp and MRP2 function in Caco-2R cell monolayers, probably, at least in part, through the release of these transporters from the apical membranes of monolayers, and the exertion of the inhibitory effect of DM-beta-CyD may require the extraction of not only cholesterol but also phospholipids from the monolayers.
PURPOSE: The purpose of this study is to reveal the contribution of membrane components to the inhibitory effect of 2,6-di-O-methyl-beta-cyclodextrin (DM-beta-CyD) on P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (MRP2) function in vinblastine-resistant Caco-2 (Caco-2R) cell monolayers. METHODS: The transport of rhodamine-123 and 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) was studied in Caco-2R cell monolayers. P-gp and MRP2 residing in the monolayers and releasing in cell supernatants were detected by Western blotting. The mRNA levels of MDR1 and MRP2 were detected by reverse transcription-polymerase chain reaction (RT-PCR) method. Cholesterol, phospholipids, and proteins were mainly determined by each assay kit. RESULTS: Of various beta-cyclodextrin derivatives (beta-CyDs), DM-beta-CyD most significantly impaired the efflux function of P-gp and MRP2 without changing cell viability and membrane integrity. The treatment with CyDs did not change the mRNA levels of MDR1 and MRP2. DM-beta-CyD lowered cholesterol content and P-gp level in caveolar membranes. In addition, DM-beta-CyD released not only cholesterol and phospholipids but also proteins including P-gp and MRP2 from apical membranes of the monolayers. CONCLUSIONS:DM-beta-CyD may impair P-gp and MRP2 function in Caco-2R cell monolayers, probably, at least in part, through the release of these transporters from the apical membranes of monolayers, and the exertion of the inhibitory effect of DM-beta-CyD may require the extraction of not only cholesterol but also phospholipids from the monolayers.
Authors: S Döppenschmitt; P Langguth; C G Regårdh; T B Andersson; C Hilgendorf; H Spahn-Langguth Journal: J Pharmacol Exp Ther Date: 1999-01 Impact factor: 4.030
Authors: Robert Jan Veldman; Karin Klappe; John Hinrichs; Ina Hummel; Gieta van der Schaaf; Hannie Sietsma; Jan Willem Kok Journal: FASEB J Date: 2002-05-08 Impact factor: 5.191
Authors: E P Kilsdonk; P G Yancey; G W Stoudt; F W Bangerter; W J Johnson; M C Phillips; G H Rothblat Journal: J Biol Chem Date: 1995-07-21 Impact factor: 5.157
Authors: Michel Demeule; Anthony Régina; Julie Jodoin; Alain Laplante; Claude Dagenais; France Berthelet; Albert Moghrabi; Richard Béliveau Journal: Vascul Pharmacol Date: 2002-06 Impact factor: 5.773
Authors: Sarah W Kamau; Stefanie D Krämer; Maja Günthert; Heidi Wunderli-Allenspach Journal: In Vitro Cell Dev Biol Anim Date: 2005 Jul-Aug Impact factor: 2.416
Authors: Jessica Davidson; Elizabeth Molitor; Samantha Moores; Sarah E Gale; Kanagaraj Subramanian; Xuntian Jiang; Rohini Sidhu; Pamela Kell; Jesse Zhang; Hideji Fujiwara; Cristin Davidson; Paul Helquist; Bruce J Melancon; Michael Grigalunas; Gang Liu; Farbod Salahi; Olaf Wiest; Xin Xu; Forbes D Porter; Nina H Pipalia; Dana L Cruz; Edward B Holson; Jean E Schaffer; Steven U Walkley; Frederick R Maxfield; Daniel S Ory Journal: Biochim Biophys Acta Mol Cell Biol Lipids Date: 2019-04-30 Impact factor: 4.698
Authors: Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra Journal: Int J Pharm Date: 2013-02-18 Impact factor: 5.875
Authors: Peter Meszaros; Karin Klappe; Annie van Dam; Pavlina T Ivanova; Stephen B Milne; David S Myers; H Alex Brown; Hjalmar Permentier; Dick Hoekstra; Jan W Kok Journal: Int J Biochem Cell Biol Date: 2012-11-23 Impact factor: 5.085